Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE5201.35236.55 (+4.76 %)
PREV CLOSE () 4964.80
OPEN PRICE () 4902.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11418
TODAY'S LOW / HIGH ()4902.65 5224.00
52 WK LOW / HIGH ()3742.9 5987.65
NSE5197.80237 (+4.78 %)
PREV CLOSE() 4960.80
OPEN PRICE () 4950.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5197.80 (11)
VOLUME 141057
TODAY'S LOW / HIGH() 4936.80 5225.00
52 WK LOW / HIGH ()3701 5993
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1950

Management Info :

Pradip Shah - Chairman Meenakshi Nevatia - Managing Director

Registered Office :

Address : The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone : 022 6693 2000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
20Jan Pfizer informs about change in senior
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
19Dec Pfizer informs about press release
Pfizer has informed that Pfizer (‘the Company’) has entered into an excl..
19Dec Pfizer enters into marketing, distribu
Pfizer and Cipla have entered into an exclusive marketing and distributi..
18Nov Pfizer inches up on launching new medi
Pfizer is currently trading at Rs. 5064.00, up by 5.75 points or 0.11% f..
17Nov Pfizer launches new medication for mig
Pfizer has launched a new medication for migraine treatment. The company..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit1418.47676
Gross Profit 1919.5 10160.9
Operating Profit 26649124.8
Net Sales 6450.322813.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 6474.50 (4.89%)
M.Cap ( in Cr)
171877.63
Astrazeneca Pharma I (BSE)
 9070.80 (1.30%)
M.Cap ( in Cr)
22677.00
Fredun Pharma (BSE)
 1882.50 (5.59%)
M.Cap ( in Cr)
1010.15
Glaxosmithkline Phar (BSE)
 2700.80 (3.09%)
M.Cap ( in Cr)
45753.18
Alkem Laboratories (BSE)
 5887.85 (1.28%)
M.Cap ( in Cr)
70398.08
Shareholding Pattern
PROMOTERS 63.92%
NON-INSTITUTION 16.32%
MUTUAL FUNDS/UTI 11.71%
FI/BANKS/INSURANCE 5.32%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX84233.64-40.28 (-0.05%)
NIFTY25953.8518.70 (0.07%)
Dow Jones 50188.1452.27 (0.10%)
Nasdaq 23102.47-136.20 (-0.59%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI